Media Database
>
Jayson Maclean

Jayson Maclean

Author at cantechletter.com at Cantech Letter

Contact this person
Email address
j*****@*******.comGet email address
Influence score
29
Location
Canada
Languages
  • English
Covering topics

    View more media outlets and journalists by signing up to Prowly

    View latest data and reach out all from one place
    Sign up for free

    Recent Articles

    cantechletter.com

    Sernova is a Speculative Buy, says Leede Jones Gable

    Leede Jones Gable provided an update on Thursday on Canadian regenerative medicine company Sernova, with analyst Douglas W. Loe commenting on a recent acquisition in the regenerative biotech space that bodes well for industry interest in companies like Sernova.
    cantechletter.com

    Three cinema stocks reviewed by Roth

    Roth Capital Partners analyst Eric Handler reviewed the latest results and coming attractions from the cinema market on Monday and reiterated a “Buy” rating on IMAX.
    cantechletter.com

    Lightspeed Commerce is a Buy, says iA Capital

    The current risk-reward ratio on Lightspeed Commerce is compelling, says iA Capital Markets analyst Neehal Upadhyaya in a Wednesday report on the stock.
    cantechletter.com

    Curaleaf has a 90 per cent upside, says Beacon

    Beacon Securities analyst Russell Stanley likes the new European acquisition by US cannabis company Curaleaf Holdings, saying in a Thursday report that it cements CURA’s position as a European leader in cannabis.
    cantechletter.com

    10 Best Canadian Dividend Stocks for Your Portfolio

    Cantech Letter hand-picks ten of the best from a range of industries, all with high yields, high market capitalization and a history of raising their dividends.
    cantechletter.com

    Innergex is a “Strong Buy,” says iA Capital

    iA Capital Markets analyst Naji Baydoun provided an update on Innergex Renewable Energy on Tuesday where he reiterated a Strong Buy on the stock.
    cantechletter.com

    Hasbro stock is a Buy, says Roth

    In a quarterly preview on Friday, Roth Capital Partners analyst Eric Handler reiterated a “Buy” rating and $74.00 target price on Hasbro.
    cantechletter.com

    WELL Health stock should hit $10, Eight Capital says

    The new acquisition by Canadian digital health company WELL Health Technologies is a sharp pickup, says Eight Capital analyst Christian Sgro.
    cantechletter.com

    Loop Industries is practically a double, says Roth

    Roth Capital Partners analyst Gerry Sweeney is keeping a bullish stance on Canadian cleantech company Loop Industries in a Friday report.
    cantechletter.com

    Kits Eyecare is heading even higher, says Beacon

    The stock has already had a tremendous 2023, but investors can expect even more upside from Kits Eyecare, according to Beacon Securities analyst Doug Cooper, who provided an update to clients on Monday.
    cantechletter.com

    D-Wave Quantum wins target raise from Roth

    Roth Capital Partners analyst Suji Desilva boosted his target price on D-Wave Quantum, saying D-Wave is about to ride a wave of market interest in quantum computing.